GE HealthCare Technologies (GEHC) Net Cash Flow (2022 - 2026)

GE HealthCare Technologies has reported Net Cash Flow for 5 years, with the latest figure at -$2.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 394.13% year-over-year to -$2.2 billion; the trailing twelve-month figure through Mar 2026 stood at -$189.0 million (down 256.6% YoY), and the FY2025 full-year result was $1.6 billion, up 232.69% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$2.2 billion, down from $488.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $1.5 billion in Q3 2024, with the low at -$2.2 billion in Q1 2026.
• Historically, Net Cash Flow has averaged $106.8 million across 5 years, with a median of $62.0 million in 2023.
• The largest YoY upside for Net Cash Flow was 50700.0% in 2023 against a maximum downside of 1150.0% in 2023.
• GE HealthCare Technologies' Net Cash Flow stood at $931.0 million in 2022, then tumbled by 93.34% to $62.0 million in 2023, then tumbled by 1074.19% to -$604.0 million in 2024, then surged by 180.79% to $488.0 million in 2025, then tumbled by 548.57% to -$2.2 billion in 2026.
• The last three Net Cash Flow figures came in at -$2.2 billion (Q1 2026), $488.0 million (Q4 2025), and $280.0 million (Q3 2025), per Business Quant data.